MusclePharm Corporation (OTCBB:MSLP)

MSLP, one of the fastest growing nutritional supplement companies in the United States with a proprietary formulation used in eight performance products, today announced the appointment of Mariel Selbovitz, MPH, as Director of Global Therapeutics Product Procurement Development. “We are thrilled to have Ms. Selbovitz join the MusclePharm team as we enter the therapeutic, nutritional supplementation market that is focused on products to meet the nutritional requirements of people living with HIV/AIDS,” stated Cory Gregory, MusclePharm's President. “MusclePharm is working to greatly expand our sales of therapeutic, nutritional supplementation and provide increased help to people in need across the globe.” Mr. Gregory continued, “We believe Ms. Selbovitz expertise and experience in the field of HIV will assist us secure distribution of MusclePharm products, such as Recon, to people living with the HIV disease in developing nations thru The Global Fund to Fight AIDS, Tuberculosis and Malaria, and The Presidents Emergency Plan for AIDS Relief (PEPFAR).”

For complete article: CLICK HERE

___________________________________

Schiff Nutrition International Inc. (NYSE:WNI)

WNI, recently announced results for the fiscal 2010 fourth quarter and year ended May 31, 2010.

Financial Results

Schiff Nutrition's net sales were $49.3 million for the three months ended May 31, 2010, compared to $45.7 million for the same period in fiscal 2009. For the fiscal 2010 fourth quarter, Schiff Nutrition reported net income of $2.4 million, or $0.08 per diluted share, compared to net income of $553,000, or $0.02 per diluted share, for the same period a year ago. Schiff Nutrition's net sales were $204.9 million for the fiscal year ended May 31, 2010, compared to $190.7 million for fiscal 2009. For fiscal 2010, Schiff Nutrition reported net income of $18.4 million, or $0.64 per diluted share, compared to net income of $10.3 million, or $0.36 per diluted share, for fiscal 2009.

For complete article: CLICK HERE

_____________________________

Tenet Healthcare Corporation (NYSE:THC)

THC announced recently the successful completion of its previously announced offering of $600 million aggregate principal amount of 8% Senior Notes due 2020. Tenet intends to use the net proceeds from the offering of the notes to purchase a portion of its 7.375% Senior Notes due 2013 in a tender offer. The notes were offered in a private placement.

The notes have not been registered under the Securities Act of 1933 and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements. This press release is neither an offer to sell nor a solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.

*******************************************
Sign-Up For Free Hot Stock Alerts At http://stockhottips.com/signup

*******************************************
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. StockHotTips.com.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold StockHotTips.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stockhottips.com/disclaimer)Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received twenty five thousand dollars in cash and seventy five thousand free trading shares from a third party (Bishop Equity Partners) for (30) days of advertising for Muscle Pharm Corp. (MSLP.OB).